Peri-procedural use of anticoagulants in radiology: an evidence-based review
- 479 Downloads
Peri-procedural anticoagulant management hinges on the balance of hemorrhagic and thrombotic complications. The radiologist is tasked with accurately assessing the hemorrhagic risk for patients undergoing procedures, taking into account procedural bleeding rates, underlying coagulopathy based on lab tests, and use of anticoagulants. The purpose of this article is to provide a contemporary review of commonly used anticoagulants and, incorporating published evidence, review their management related to image-guided procedures.
KeywordsAnticoagulant Biopsy Drainage Complication Hemorrhage
Compliance with ethical standards
No funding was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
- 4.Narouze S, Benzon HT, Provenzano DA, et al. (2015) Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med 40(3):182–212CrossRefGoogle Scholar
- 13.Abdulsattar Y, Ternas T, Garcia D (2011) Vorapaxar: targeting a novel antiplatelet pathway. Pharm Ther 36(9):564–568Google Scholar
- 25.CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women (1994). CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343(8898):619–629Google Scholar
- 26.Whellan DJ, Tricoci P, Chen E, et al. (2014) Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J Am Coll Cardiol 63(11):1048–1057CrossRefGoogle Scholar
- 45.Imbruvica (R) [package insert]. Pharmacyclics LLC, Sunnyvale, CA; June 2016. Available from: https://www.imbruvicahcp.com/docs/librariesprovider2/pdf-downloads/prescribing_information.pdf. Accessed 14 June 2016